{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:57Z","timestamp":1772165757843,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by challenging early diagnosis and poor prognosis. It is believed that coagulation has an impact on the tumor microenvironment of PDAC. The aim of this study is to further distinguish coagulation-related genes and investigate immune infiltration in PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We gathered two subtypes of coagulation-related genes from the KEGG database, and acquired transcriptome sequencing data and clinical information on PDAC from The Cancer Genome Atlas (TCGA) database. Using an unsupervised clustering method, we categorized patients into distinct clusters. We investigated the mutation frequency to explore genomic features and performed enrichment analysis, utilizing Gene Ontology (GO) and Kyoto Encyclopedia of Genes (KEGG) to explore pathways. CIBERSORT was used to analyze the relationship between tumor immune infiltration and the two clusters. A prognostic model was created for risk stratification, and a nomogram was established to assist in determining the risk score. The response to immunotherapy was assessed using the IMvigor210 cohort. Finally, PDAC patients were recruited, and experimental samples were collected to validate the infiltration of neutrophils using immunohistochemistry. In addition, and identify the ITGA2 expression and function were identified by analyzing single cell sequencing data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two coagulation-related clusters were established based on the coagulation pathways present in PDAC patients. Functional enrichment analysis revealed different pathways in the two clusters. Approximately 49.4% of PDAC patients experienced DNA mutation in coagulation-related genes. Patients in the two clusters displayed significant differences in terms of immune cell infiltration, immune checkpoint, tumor microenvironment and TMB. We developed a 4-gene prognostic stratified model through LASSO analysis. Based on the risk score, the nomogram can accurately predict the prognosis in PDAC patients. We identified ITGA2 as a hub gene, which linked to poor overall survival (OS) and short disease-free survival (DFS). Single-cell sequencing analysis demonstrated that ITGA2 was expressed by ductal cells in PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study demonstrated the correlation between coagulation-related genes and the tumor immune microenvironment. The stratified model can predict the prognosis and calculate the benefits of drug therapy, thus providing the recommendations for clinical personalized treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-023-11032-9","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T05:02:29Z","timestamp":1688014949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Di","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-ping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang-yong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-cheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"11032_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"11032_CR2","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1038\/s41598-017-08436-6","volume":"7","author":"R Chen","year":"2017","unstructured":"Chen R, Lai LA, Sullivan Y, Wong M, Wang L, Riddell J, Jung L, Pillarisetty VG, Brentnall TA, Pan S. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Sci Rep. 2017;7:7950.","journal-title":"Sci Rep"},{"key":"11032_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/cancers14040985","volume":"14","author":"S Robatel","year":"2022","unstructured":"Robatel S, Schenk M. Current limitations and novel perspectives in pancreatic cancer treatment. Cancers (Basel). 2022;14:985.","journal-title":"Cancers (Basel)"},{"key":"11032_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","volume":"31","author":"CJ Halbrook","year":"2017","unstructured":"Halbrook CJ, Lyssiotis CA. Employing metabolism to improve the diagnosis and treatment of pancreatic cancer. Cancer Cell. 2017;31:5\u201319.","journal-title":"Cancer Cell"},{"key":"11032_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AYY. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022;8:11.","journal-title":"Nat Rev Dis Primers"},{"key":"11032_CR6","first-page":"1181","volume":"19","author":"MB Streiff","year":"2021","unstructured":"Streiff MB, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, Fertrin KY, Fogerty AE, Gao S, Goldhaber SZ, et al. Cancer-associated venous thromboembolic disease, version 2. 2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:1181\u2013201.","journal-title":"J Natl Compr Canc Netw"},{"key":"11032_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","volume":"70","author":"BB Navi","year":"2017","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70:926\u201338.","journal-title":"J Am Coll Cardiol"},{"key":"11032_CR8","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","volume":"30","author":"S Seng","year":"2012","unstructured":"Seng S, Liu Z, Chiu SK, Proverbs-Singh T, Sonpavde G, Choueiri TK, Tsao CK, Yu M, Hahn NM, Oh WK, Galsky MD. Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol. 2012;30:4416\u201326.","journal-title":"J Clin Oncol"},{"key":"11032_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1055\/s-0040-1718926","volume":"47","author":"J Costa","year":"2021","unstructured":"Costa J, Ara\u00fajo A. Cancer-related venous thromboembolism: from pathogenesis to risk assessment. Semin Thromb Hemost. 2021;47:669\u201376.","journal-title":"Semin Thromb Hemost"},{"key":"11032_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.trsl.2020.06.012","volume":"225","author":"AS Kim","year":"2020","unstructured":"Kim AS, Khorana AA, McCrae KR. Mechanisms and biomarkers of cancer-associated thrombosis. Transl Res. 2020;225:33\u201353.","journal-title":"Transl Res"},{"key":"11032_CR11","doi-asserted-by":"publisher","first-page":"180119","DOI":"10.1183\/16000617.0119-2018","volume":"28","author":"CJ Fernandes","year":"2019","unstructured":"Fernandes CJ, Morinaga LTK, Alves JLJ, Castro MA, Calderaro D, Jardim CVP, Souza R. Cancer-associated thrombosis: the when, how and why. Eur Respir Rev. 2019;28:180119.","journal-title":"Eur Respir Rev"},{"key":"11032_CR12","doi-asserted-by":"publisher","first-page":"26453","DOI":"10.18632\/oncotarget.25458","volume":"9","author":"D Faille","year":"2018","unstructured":"Faille D, Bourrienne MC, de Raucourt E, de Chaisemartin L, Granger V, Lacroix R, Panicot-Dubois L, Hammel P, L\u00e9vy P, Ruszniewski P, et al. Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process. Oncotarget. 2018;9:26453\u201365.","journal-title":"Oncotarget"},{"key":"11032_CR13","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1161\/CIRCRESAHA.121.318225","volume":"128","author":"ME Colling","year":"2021","unstructured":"Colling ME, Tourdot BE, Kanthi Y. Inflammation, infection and venous thromboembolism. Circ Res. 2021;128:2017\u201336.","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"11032_CR14","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.thromres.2021.12.018","volume":"213","author":"A Rosell","year":"2022","unstructured":"Rosell A, Martinod K, Mackman N, Th\u00e5lin C. Neutrophil extracellular traps and cancer-associated thrombosis. Thromb Res. 2022;213(Suppl 1):S35-s41.","journal-title":"Thromb Res"},{"key":"11032_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.trecan.2021.12.008","volume":"8","author":"A Galmiche","year":"2022","unstructured":"Galmiche A, Rak J, Roumenina LT, Saidak Z. Coagulome and the tumor microenvironment: an actionable interplay. Trends Cancer. 2022;8:369\u201383.","journal-title":"Trends Cancer"},{"key":"11032_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.948898","volume":"9","author":"GA Noubissi Nzeteu","year":"2022","unstructured":"Noubissi Nzeteu GA, Gibbs BF, Kotnik N, Troja A, Bockhorn M, Meyer NH. Nanoparticle-based immunotherapy of pancreatic cancer. Front Mol Biosci. 2022;9: 948898.","journal-title":"Front Mol Biosci"},{"key":"11032_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00262-020-02739-w","volume":"70","author":"Z Saidak","year":"2021","unstructured":"Saidak Z, Soudet S, Lottin M, Salle V, Sevestre MA, Clatot F, Galmiche A. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment. Cancer Immunol Immunother. 2021;70:923\u201333.","journal-title":"Cancer Immunol Immunother"},{"key":"11032_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00401-021-02401-4","volume":"143","author":"SM Markwell","year":"2022","unstructured":"Markwell SM, Ross JL, Olson CL, Brat DJ. Necrotic reshaping of the glioma microenvironment drives disease progression. Acta Neuropathol. 2022;143:291\u2013310.","journal-title":"Acta Neuropathol"},{"key":"11032_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.immuni.2019.03.003","volume":"50","author":"LC Burzynski","year":"2019","unstructured":"Burzynski LC, Humphry M, Pyrillou K, Wiggins KA, Chan JNE, Figg N, Kitt LL, Summers C, Tatham KC, Martin PB, et al. The coagulation and immune systems are directly linked through the activation of interleukin-1\u03b1 by thrombin. Immunity. 2019;50:1033-1042.e1036.","journal-title":"Immunity"},{"issue":"Suppl 1","key":"11032_CR20","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/S0049-3848(20)30406-0","volume":"191","author":"W Ruf","year":"2020","unstructured":"Ruf W, Graf C. Coagulation signaling and cancer immunotherapy. Thromb Res. 2020;191(Suppl 1):S106-s111.","journal-title":"Thromb Res"},{"key":"11032_CR21","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587-d592.","journal-title":"Nucleic Acids Res"},{"key":"11032_CR22","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"11032_CR23","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1093\/annonc\/mdx518","volume":"28","author":"A Necchi","year":"2017","unstructured":"Necchi A, Joseph RW, Loriot Y, Hoffman-Censits J, Perez-Gracia JL, Petrylak DP, Derleth CL, Tayama D, Zhu Q, Ding B, et al. Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study. Ann Oncol. 2017;28:3044\u201350.","journal-title":"Ann Oncol"},{"key":"11032_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.709986","volume":"12","author":"H Zhong","year":"2021","unstructured":"Zhong H, Liu S, Cao F, Zhao Y, Zhou J, Tang F, Peng Z, Li Y, Xu S, Wang C, et al. Dissecting tumor antigens and immune subtypes of glioma to develop mRNA vaccine. Front Immunol. 2021;12: 709986.","journal-title":"Front Immunol"},{"key":"11032_CR25","doi-asserted-by":"publisher","first-page":"1005271","DOI":"10.3389\/fgene.2022.1005271","volume":"13","author":"R Xiong","year":"2022","unstructured":"Xiong R, Wang H, Li Y, Zheng J, Cheng Y, Liu S, Yang G. Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma. Front Genet. 2022;13:1005271.","journal-title":"Front Genet"},{"key":"11032_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724741","volume":"12","author":"XS Liu","year":"2021","unstructured":"Liu XS, Zhou LM, Yuan LL, Gao Y, Kui XY, Liu XY, Pei ZJ. NPM1 is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and associated with m6a modification and glycolysis. Front Immunol. 2021;12: 724741.","journal-title":"Front Immunol"},{"key":"11032_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636093","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Ma B, Jiang P, Yang HM. Identification of methylation-regulated differentially expressed genes and related pathways in hepatocellular carcinoma: a study based on TCGA database and bioinformatics analysis. Front Oncol. 2021;11: 636093.","journal-title":"Front Oncol"},{"key":"11032_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12967-022-03393-9","volume":"20","author":"J He","year":"2022","unstructured":"He J, Chen Z, Xue Q, Sun P, Wang Y, Zhu C, Shi W. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. J Transl Med. 2022;20:186.","journal-title":"J Transl Med"},{"key":"11032_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fmed.2020.00064","volume":"7","author":"M Xu","year":"2020","unstructured":"Xu M, Li Y, Li W, Zhao Q, Zhang Q, Le K, Huang Z, Yi P. Immune and stroma related genes in breast cancer: a comprehensive analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database. Front Med (Lausanne). 2020;7:64.","journal-title":"Front Med (Lausanne)"},{"key":"11032_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.731048","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Tang L, Liu Z, Luo C, Cheng Q. Hypoxia-related lncRNA correlates with prognosis and immune microenvironment in lower-grade glioma. Front Immunol. 2021;12: 731048.","journal-title":"Front Immunol"},{"key":"11032_CR31","doi-asserted-by":"publisher","first-page":"e002467","DOI":"10.1136\/jitc-2021-002467","volume":"9","author":"D Zeng","year":"2021","unstructured":"Zeng D, Wu J, Luo H, Li Y, Xiao J, Peng J, Ye Z, Zhou R, Yu Y, Wang G, et al. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer. J Immunother Cancer. 2021;9:e002467.","journal-title":"J Immunother Cancer"},{"key":"11032_CR32","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/nar\/gkx1143","volume":"46","author":"KC Cotto","year":"2018","unstructured":"Cotto KC, Wagner AH, Feng YY, Kiwala S, Coffman AC, Spies G, Wollam A, Spies NC, Griffith OL, Griffith M. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 2018;46:1068\u201373.","journal-title":"Nucleic Acids Res"},{"key":"11032_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105370","volume":"164","author":"D Xu","year":"2021","unstructured":"Xu D, Wang Y, Liu X, Zhou K, Wu J, Chen J, Chen C, Chen L, Zheng J. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma. Pharmacol Res. 2021;164: 105370.","journal-title":"Pharmacol Res"},{"key":"11032_CR34","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, Wang L, Lim HB, Oh G, Jing X, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nat Commun. 2023;14:797.","journal-title":"Nat Commun"},{"key":"11032_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104319","volume":"85","author":"J Wang","year":"2022","unstructured":"Wang J, Ren M, Yu J, Hu M, Wang X, Ma W, Jiang X, Cui J. Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer. EBioMedicine. 2022;85: 104319.","journal-title":"EBioMedicine"},{"key":"11032_CR36","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using cell chat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"11032_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","volume":"22","author":"AA Connor","year":"2022","unstructured":"Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2022;22:131\u201342.","journal-title":"Nat Rev Cancer"},{"key":"11032_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-019-0510-x","volume":"121","author":"E Campello","year":"2019","unstructured":"Campello E, Ilich A, Simioni P, Key NS. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br J Cancer. 2019;121:359\u201371.","journal-title":"Br J Cancer"},{"key":"11032_CR39","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/cncr.23062","volume":"110","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110:2339\u201346.","journal-title":"Cancer"},{"key":"11032_CR40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1053\/j.gastro.2019.12.009","volume":"158","author":"C Frere","year":"2020","unstructured":"Frere C, Bournet B, Gourgou S, Fraisse J, Canivet C, Connors JM, Buscail L, Farge D. Incidence of venous thromboembolism in patients with newly diagnosed pancreatic cancer and factors associated with outcomes. Gastroenterology. 2020;158:1346-1358.e1344.","journal-title":"Gastroenterology"},{"key":"11032_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, Xu Y, Lesker TR, Sch\u00f6nlein M, Konczalla L, Giannou AD, Pelczar P, Kylies D, Puelles VG, Bielecka AA, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615:168\u201374.","journal-title":"Nature"},{"key":"11032_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ijc.34466","volume":"153","author":"H Zhong","year":"2023","unstructured":"Zhong H, Liu S, Zhu J, Wu L. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk. Int J Cancer. 2023;153:103\u201310.","journal-title":"Int J Cancer"},{"key":"11032_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2022.101346","volume":"35","author":"E Campello","year":"2022","unstructured":"Campello E, Bosch F, Simion C, Spiezia L, Simioni P. Mechanisms of thrombosis in pancreatic ductal adenocarcinoma. Best Pract Res Clin Haematol. 2022;35: 101346.","journal-title":"Best Pract Res Clin Haematol"},{"key":"11032_CR44","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1186\/s12885-018-5154-3","volume":"18","author":"JS Kim","year":"2018","unstructured":"Kim JS, Kang EJ, Kim DS, Choi YJ, Lee SY, Kim HJ, Seo HY, Kim JS. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study. BMC Cancer. 2018;18:1260.","journal-title":"BMC Cancer"},{"key":"11032_CR45","first-page":"325","volume":"4","author":"D Ansari","year":"2015","unstructured":"Ansari D, Ansari D, Andersson R, Andr\u00e9n-Sandberg \u00c5. Pancreatic cancer and thromboembolic disease, 150 years after Trousseau. Hepatobiliary Surg Nutr. 2015;4:325\u201335.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"11032_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clcc.2018.01.008","volume":"17","author":"A Mier-Hicks","year":"2018","unstructured":"Mier-Hicks A, Raj M, Do RK, Yu KH, Lowery MA, Varghese A, O\u2019Reilly EM. Incidence, management, and implications of visceral thrombosis in pancreatic ductal adenocarcinoma. Clin Colorectal Cancer. 2018;17:121\u20138.","journal-title":"Clin Colorectal Cancer"},{"issue":"Suppl 1","key":"11032_CR47","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0049-3848(20)30395-9","volume":"191","author":"M Marchetti","year":"2020","unstructured":"Marchetti M, Falanga A. Hemostatic biomarkers in occult cancer and cancer risk prediction. Thromb Res. 2020;191(Suppl 1):S37-s42.","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"11032_CR48","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/S0049-3848(20)30408-4","volume":"191","author":"R Cantrell","year":"2020","unstructured":"Cantrell R, Palumbo JS. The thrombin-inflammation axis in cancer progression. Thromb Res. 2020;191(Suppl 1):S117-s122.","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"11032_CR49","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1016\/j.thromres.2018.01.021","volume":"164","author":"N Tawil","year":"2018","unstructured":"Tawil N, Chennakrishnaiah S, Bassawon R, Johnson R, D\u2019Asti E, Rak J. Single cell coagulomes as constituents of the oncogene-driven coagulant phenotype in brain tumours. Thromb Res. 2018;164(Suppl 1):S136-s142.","journal-title":"Thromb Res"},{"key":"11032_CR50","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.3390\/cancers13153839","volume":"13","author":"Y Hisada","year":"2021","unstructured":"Hisada Y, Mackman N. Tissue factor and extracellular vesicles: activation of coagulation and impact on survival in cancer. Cancers (Basel). 2021;13:3839.","journal-title":"Cancers (Basel)"},{"key":"11032_CR51","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1186\/s12885-020-07548-z","volume":"20","author":"A John","year":"2020","unstructured":"John A, G\u00fcnes C, Bolenz C, Vidal YSS, Bauer AT, Schneider SW, Gorzelanny C. Bladder cancer-derived interleukin-1 converts the vascular endothelium into a pro-inflammatory and pro-coagulatory surface. BMC Cancer. 2020;20:1178.","journal-title":"BMC Cancer"},{"key":"11032_CR52","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1016\/j.cell.2022.10.006","volume":"185","author":"F Baharom","year":"2022","unstructured":"Baharom F, Ramirez-Valdez RA, Khalilnezhad A, Khalilnezhad S, Dillon M, Hermans D, Fussell S, Tobin KKS, Dutertre CA, Lynn GM, et al. Systemic vaccination induces CD8(+) T cells and remodels the tumor microenvironment. Cell. 2022;185:4317-4332.e4315.","journal-title":"Cell"},{"key":"11032_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2017.08.006","volume":"407","author":"M Feng","year":"2017","unstructured":"Feng M, Xiong G, Cao Z, Yang G, Zheng S, Song X, You L, Zheng L, Zhang T, Zhao Y. PD-1\/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett. 2017;407:57\u201365.","journal-title":"Cancer Lett"},{"key":"11032_CR54","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8065","volume":"4","author":"R Pei","year":"2021","unstructured":"Pei R, Shi Y, Lv S, Dai T, Zhang F, Liu S, Wu B. Nivolumab vs pembrolizumab for treatment of US patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a network meta-analysis and cost-effectiveness analysis. JAMA Netw Open. 2021;4: e218065.","journal-title":"JAMA Netw Open"},{"key":"11032_CR55","doi-asserted-by":"publisher","first-page":"e002875","DOI":"10.1136\/jitc-2021-002875","volume":"9","author":"C Yang","year":"2021","unstructured":"Yang C, Wang Z, Li L, Zhang Z, Jin X, Wu P, Sun S, Pan J, Su K, Jia F, et al. Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis. J Immunother Cancer. 2021;9:e002875.","journal-title":"J Immunother Cancer"},{"key":"11032_CR56","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.3390\/cancers14143339","volume":"14","author":"M Mitsis","year":"2022","unstructured":"Mitsis M, Drosou P, Tatsis V, Markopoulos GS. Neutrophil extracellular traps and pancreatic cancer development: a vicious cycle. Cancers (Basel). 2022;14:3339.","journal-title":"Cancers (Basel)"},{"key":"11032_CR57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","volume":"39","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Cong M, Li J, He D, Wu Q, Tian P, Wang Y, Yang S, Liang C, Liang Y, et al. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell. 2021;39:423-437.e427.","journal-title":"Cancer Cell"},{"key":"11032_CR58","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2353\/ajpath.2010.100017","volume":"177","author":"J Dennis","year":"2010","unstructured":"Dennis J, Meehan DT, Delimont D, Zallocchi M, Perry GA, O\u2019Brien S, Tu H, Pihlajaniemi T, Cosgrove D. Collagen XIII induced in vascular endothelium mediates alpha1beta1 integrin-dependent transmigration of monocytes in renal fibrosis. Am J Pathol. 2010;177:2527\u201340.","journal-title":"Am J Pathol"},{"key":"11032_CR59","first-page":"241","volume":"17","author":"ZH Li","year":"2019","unstructured":"Li ZH, Zhou Y, Ding YX, Guo QL, Zhao L. Roles of integrin in tumor development and the target inhibitors. Chin J Nat Med. 2019;17:241\u201351.","journal-title":"Chin J Nat Med"},{"key":"11032_CR60","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1002\/jcp.26866","volume":"233","author":"XY Lian","year":"2018","unstructured":"Lian XY, Zhang W, Wu DH, Ma JC, Zhou JD, Zhang ZH, Wen XM, Xu ZJ, Lin J, Qian J. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia. J Cell Physiol. 2018;233:9584\u201393.","journal-title":"J Cell Physiol"},{"key":"11032_CR61","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.18632\/aging.102954","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma L, Sun Y, Li D, Li H, Jin X, Ren D. Overexpressed ITGA2 contributes to paclitaxel resistance by ovarian cancer cells through the activation of the AKT\/FoxO1 pathway. Aging (Albany NY). 2020;12:5336\u201351.","journal-title":"Aging (Albany NY)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-11032-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T05:05:45Z","timestamp":1688015145000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-11032-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["11032"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-11032-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2514483\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Beijing Chaoyang Hospital (No. 2020-D-301). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"601"}}